Stay updated on Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated to v3.5.3, replacing the previous v3.5.2. This represents a minor documentation/versioning update and does not change study details or eligibility content.
    Difference
    0.0%
    Check dated 2026-04-30T17:27:24.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.2; the v3.5.0 label was removed. This is a routine site maintenance update and does not affect the study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-04-16T10:22:20.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page version was updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-25T20:17:07.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T16:09:32.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.2 and the prior funding-status notice was removed; these are site-wide maintenance updates that do not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T03:15:26.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with links to cc.nih.gov and opm.gov for status updates. Updated the page revision stamp to v3.4.1, replacing the prior v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T01:51:43.000Z thumbnail image

Stay in the know with updates to Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page.